Thursday morning brought mixed signals for U.S. stock futures, with the Dow futures edging up around 0.1% while several notable names struggled in pre-market action.
Pre-Market Movers: Snowflake Slides Despite Earnings Beat While Symbotic Tumbles on Share Offering
Get ADC TELECOMMUNICATIONS Alerts
Weekly insights + SMS alerts
Snowflake's Puzzling Decline
The morning's head-scratcher comes from Snowflake Inc. (SNOW), which is getting hammered despite posting a solid earnings beat. The AI data cloud company delivered third-quarter revenue of $1.21 billion, topping analyst estimates of $1.18 billion. Adjusted earnings came in at 35 cents per share, beating expectations of 31 cents per share.
So why the sell-off? Sometimes beating estimates isn't enough if guidance disappoints or growth rates decelerate, though the market's reaction suggests investors found something less than thrilling in the details. Snowflake shares tumbled 8.6% to $241.85 in pre-market trading.
Other Notable Decliners
Net Lease Office Properties (NLOP) led the decliners, plunging 14.7% to $25.19 in pre-market action. That's a rough morning for the office property REIT.
Symbotic Inc. (SYM) dropped 10.5% to $65.50 after announcing a 10 million share offering. The warehouse automation company plans to sell 6.5 million new shares while a selling stockholder will offload another 3.5 million. Dilution fears are hitting the stock hard.
Capricor Therapeutics Inc. (CAPR) gave back some of Wednesday's massive gains, falling 8.4% to $27.45. This comes after the biotech rocketed 371% higher Wednesday on news that its Phase 3 HOPE-3 trial evaluating deramiocel cell therapy for Duchenne Muscular Dystrophy met its primary endpoint and secondary cardiac endpoint. A pullback after a move like that isn't exactly shocking.
ADC Therapeutics SA (ADCT) declined 8.1% to $3.63, extending Wednesday's 14% drop. The company recently reported updated data from its LOTIS-7 trial evaluating Zynlonta in combination with Glofitamab in relapsed/refractory DLBCL patients, and the market's reaction suggests the data didn't impress.
Rounding out the decliners: Lineage Cell Therapeutics Inc. (LCTX) fell 7.1% to $1.56, Koninklijke Philips NV (PHG) dropped 6.8% to $26.11, Omeros Corp. (OMER) declined 4.2% to $10.18, and Methanex Corp. (MEOH) slipped 3.8% to $35.95 in pre-market trading.
More News

Markets Hit New Highs Amid Ceasefire News, But Oil Jumps on Hormuz Tensions
Make This One Trade at 2:59 PM on Friday Afternoon, and you'll Thank Me Monday Morning

Operation 'Economic Fury': U.S. Unleashes Financial Firepower on Iran as Hegseth Delivers 'Choose Wisely' Ultimatum

TSMC's AI Boom: The Chip Giant Beats Forecasts and Tells Rivals There Are 'No Shortcuts'

Oil's At $90, Gas Is Over $4, But These 7 Energy Stocks Are Priced Like The Crisis Is Over
Remember Tesla?

Jensen Huang Says Nvidia Is 'Not A Car' And Its AI Dominance Isn't Going Anywhere

U.S. Bancorp Beats Earnings, But Investors Focus on Rising Credit Costs
Get ADC TELECOMMUNICATIONS Alerts
Real-time alerts on price moves, news, and trading opportunities.
Join 20,000+ investors. No spam, ever.
Featured Articles
View all news
Markets Hit New Highs Amid Ceasefire News, But Oil Jumps on Hormuz Tensions
Make This One Trade at 2:59 PM on Friday Afternoon, and you'll Thank Me Monday Morning (Ad)

Operation 'Economic Fury': U.S. Unleashes Financial Firepower on Iran as Hegseth Delivers 'Choose Wisely' Ultimatum

TSMC's AI Boom: The Chip Giant Beats Forecasts and Tells Rivals There Are 'No Shortcuts'

Oil's At $90, Gas Is Over $4, But These 7 Energy Stocks Are Priced Like The Crisis Is Over
Trump's Secret Retirement Fund (Ad)

Jensen Huang Says Nvidia Is 'Not A Car' And Its AI Dominance Isn't Going Anywhere





